Markus Maeurer

Champalimaud Foundation — Portugal

Medicine · Health Sciences

75h-index21.0kcitations439works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(120), Immunotherapy and Immune Responses(115), Immune Cell Function and Interaction(79), T-cell and B-cell Immunology(72), Mycobacterium research and diagnosis(47)

Publications438 total

TCRcloud: a global visualization tool for T-cell and B-cell receptor transcripts
Journal of Translational Medicine·2026Open Access
Global health at crossroads
DiRROS repository (University of Maribor)·2026
Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
World Journal of Emergency Surgery·2025· 1 citedOpen Access
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines
2025· 1 citedOpen Access
Protecting the future of vaccine development amidst US funding withdrawal for mRNA vaccine research
The Lancet Microbe·2025· 1 citedOpen Access
Global Resurgence of Measles: Turning the Tide through a Bold Agenda for Prevention and Control
International Journal of Infectious Diseases·2025· 5 citedOpen Access
Mucosal-associated invariant T-cells in pulmonary pathophysiology
Current Opinion in Pulmonary Medicine·2025Open Access
Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forward
IJID Regions·2025· 2 citedOpen Access
Harnessing faith-based organisations for global health equity
The Lancet·2024· 6 citedOpen Access
5 years of COVID-19: equity must lead the next pandemic response in a fractured multipolar world
The Lancet Respiratory Medicine·2024· 2 cited
Preoperative Inflammatory Scores Do Not Accurately Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma After Resection: A Systematic Review and Meta‐Analysis
Cancer Medicine·2024Open Access
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy
Cells·2024· 48 citedOpen Access
Perspectives on development and advancement of new tuberculosis vaccines
International Journal of Infectious Diseases·2024· 21 citedOpen Access
Editorial: Emerging talents in cancer immunity and immunotherapy: 2022
Frontiers in Immunology·2023Open Access
MRI, FDG-PET/CT and Image-Guidance for Re-Irradiation of Locoregionally Recurrent or Second Primary Head-and-Neck Squamous Cell Carcinoma Patients – Results of a Multicenter Cohort Study
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
Building smart CAR T cell therapies: The path to overcome current challenges
Cancer Cell·2023· 13 cited
Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
2023Open Access
Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
2023Open Access
Supplementary Figure from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
2023Open Access
Supplementary Data from The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
2023Open Access
page 1 of 22Next →

Frequent Co-authors

Alimuddin Zumla(33), Peter Mwaba(15), Matthew Bates(11), Michael Höelscher(11), Marco Schito(11), Giuseppe Ippolito(11), Giovanni Battista Migliori(10), Timothy D. McHugh(8), Jeremiah Chakaya(8), Nathan Kapata(7), Ziad A. Memish(7), Martin Rao(7), Ben J. Marais(6), Ibrahim Abubakar(6), Chao Zhang(5), Jin‐Wen Song(5), Fu‐Sheng Wang(5), Ruth McNerney(5), Peter Kim(5), Chiara Agrati(5)